Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02POH
|
||||
Former ID |
DIB015744
|
||||
Drug Name |
TA-7906
|
||||
Synonyms |
T-2585; PDE4 inhibitor (skin disease), Maruho; PDE4 inhibitors (inflammation), Tanabe Seiyaku; T-2585.HCl
|
||||
Indication | Atopic dermatitis [ICD9: 691.8, 692.9; ICD10:L00-L99] | Phase 2 | [548322] | ||
Company |
Tanabe Seiyaku Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
n1(nc(c2c(c1=O)cccc2)c1nccs1)c1cc(c2c3c(cc(c(c3)OCC)OCC<br />)cc(n2)CO)ccn1
|
||||
CAS Number |
CAS 186461-26-7
|
||||
Target and Pathway | |||||
Target(s) | Type IV phosphodiesterase | Target Info | Inhibitor | [526360] | |
CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [526360] | ||
CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [526360] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
PathWhiz Pathway | Purine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.